Abstract
Cancer Biotherapy & RadiopharmaceuticalsVol. 36, No. 8 RetractionsOpen AccessRetraction of: miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1 (doi: 10.1089/cbr.2018.2749)This article retracts the following:Retracted: miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1Published Online:13 Oct 2021https://doi.org/10.1089/cbr.2018.2749.retractAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail Cancer Biotherapy and Radiopharmaceuticals officially retracts the paper entitled, “miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1,” by Yong Liu and Mei Zhang (Cancer Biother Radiopharm. 2019;34(6):398–404; doi: 10.1089/cbr.2018.2749) due to the discovery that the paper was submitted from a paper mill. This is a violation of the journal's standard protocols and is considered an infraction against the rigorous standards of scientific publishing.The Editor and Publisher of Cancer Biotherapy and Radiopharmaceuticals are committed to preserving the scientific literature and the community it serves, and does not tolerate any misconduct.FiguresReferencesRelatedDetailsRelated articlesRetracted: miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 110 Aug 2019Cancer Biotherapy & Radiopharmaceuticals Volume 36Issue 8Oct 2021 InformationCopyright 2021, Mary Ann Liebert, Inc., publishersTo cite this article:Retraction of: miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1 (doi: 10.1089/cbr.2018.2749).Cancer Biotherapy and Radiopharmaceuticals.Oct 2021.705-705.http://doi.org/10.1089/cbr.2018.2749.retractcreative commons licensePublished in Volume: 36 Issue 8: October 13, 2021Online Ahead of Print:August 12, 2021PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
